COLOMBO, NICOLETTA

COLOMBO, NICOLETTA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 400 (tempo di esecuzione: 0.043 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial 01 - Articolo su rivista 2024 Colombo, Nicoletta +
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab 01 - Articolo su rivista 2024 Colombo, Nicoletta +
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer 01 - Articolo su rivista 2024 Colombo N. +
Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma 01 - Articolo su rivista 2024 Colombo, N +
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease 01 - Articolo su rivista 2024 Colombo N. +
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention 01 - Articolo su rivista 2024 Colombo N. +
Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study 01 - Articolo su rivista 2024 Colombo, Nicoletta +
Letter to the editor-The new FIGO staging system for endometrial cancer: Is the paradigm shift clinically feasible? 01 - Articolo su rivista 2024 Colombo, N +
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations 01 - Articolo su rivista 2024 Colombo, Nicoletta +
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial 01 - Articolo su rivista 2024 Colombo N. +
Photocatalytic Radical Coupling of Organoborates with α-Halogenated Electron-Poor Olefins 01 - Articolo su rivista 2024 Colombo, N +
Reply to P.-H. Luo et al 01 - Articolo su rivista 2024 Colombo, N +
Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey 01 - Articolo su rivista 2024 Colombo N. +
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence 01 - Articolo su rivista 2023 Colombo, Nicoletta +
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial 01 - Articolo su rivista 2023 Colombo N. +
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 01 - Articolo su rivista 2023 Colombo N. +
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 01 - Articolo su rivista 2023 Colombo, NicolettaLandoni, FabioLissoni, Andrea +
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation 01 - Articolo su rivista 2023 Colombo, Nicoletta +
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial 01 - Articolo su rivista 2023 Colombo N. +
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study 01 - Articolo su rivista 2023 Colombo, Nicoletta +